FDA panel sees risk in long-used osteoporosis drug
WASHINGTON (AP) ? A panel of federal health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer.
View full post on Health News Headlines – Yahoo! News
Leave a Reply